[HTML][HTML] Measuring the biological effect of presurgical metformin treatment in endometrial cancer
VN Sivalingam, S Kitson, R McVey, C Roberts… - British journal of …, 2016 - nature.com
Background: Preclinical studies in endometrial cancer (EC) show that metformin reduces
cellular proliferation by PI3K-AKT-mTOR inhibition. We tested the hypothesis that short-term …
cellular proliferation by PI3K-AKT-mTOR inhibition. We tested the hypothesis that short-term …
Measuring the biological effect of presurgical metformin treatment in endometrial cancer
VN Sivalingam, S Kitson, R McVey… - British journal of …, 2016 - pubmed.ncbi.nlm.nih.gov
Background Preclinical studies in endometrial cancer (EC) show that metformin reduces
cellular proliferation by PI3K-AKT-mTOR inhibition. We tested the hypothesis that short-term …
cellular proliferation by PI3K-AKT-mTOR inhibition. We tested the hypothesis that short-term …
[HTML][HTML] Measuring the biological effect of presurgical metformin treatment in endometrial cancer
VN Sivalingam, S Kitson, R McVey… - British Journal of …, 2016 - ncbi.nlm.nih.gov
Background: Preclinical studies in endometrial cancer (EC) show that metformin reduces
cellular proliferation by PI3K-AKT-mTOR inhibition. We tested the hypothesis that short-term …
cellular proliferation by PI3K-AKT-mTOR inhibition. We tested the hypothesis that short-term …
Measuring the biological effect of presurgical metformin treatment in endometrial cancer
VN Sivalingam, S Kitson, R McVey… - British Journal of …, 2016 - research.manchester.ac.uk
BACKGROUND: Preclinical studies in endometrial cancer (EC) show that metformin reduces
cellular proliferation by PI3K-AKT-mTOR inhibition. We tested the hypothesis that short-term …
cellular proliferation by PI3K-AKT-mTOR inhibition. We tested the hypothesis that short-term …
[引用][C] Measuring the biological effect of presurgical metformin treatment in endometrial cancer
VN Sivalingam, S Kitson, R McVey, C Roberts… - British Journal of …, 2016 - cir.nii.ac.jp
Measuring the biological effect of presurgical metformin treatment in endometrial cancer.
VN Sivalingam, S Kitson, R McVey… - British Journal of …, 2016 - europepmc.org
Background Preclinical studies in endometrial cancer (EC) show that metformin reduces
cellular proliferation by PI3K-AKT-mTOR inhibition. We tested the hypothesis that short-term …
cellular proliferation by PI3K-AKT-mTOR inhibition. We tested the hypothesis that short-term …